This article is more than 5 years old. Information may no longer be current.

Spark Therapeutics announces public offering of common stock

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Spark Therapeutics will offer $300 million in shares of common stock, according to a company press release.

Underwriters will be granted an option to purchase up to an additional 15% of the shares of common stock offered in the public offering at the public offering price for a period of 30 days, the release said.

The offering is jointly managed by J.P. Morgan Securities, Goldman Sachs & Co. and Cowen and Company and is subject to market and other conditions.